Introduction.-1. Isolation of bone marrow stromal cells from bone marrow by using a filtering device (method).-2. Hematopoietic stem cell frequency estimate: statistical approach to model limiting dilution competitive repopulation assays.3-. Characteristics of cord blood stem cells: role of substance p (sp) and calcitonin gene-related peptide (cgrp).-4. A new concept of stem cell disorders, and the rationale for transplantation of normal stem cells.-5. Differentiation of human embryonic stem cells into functional hepatocyte-like cells (method).-6. Stem cell mobilization: an overview.-7. Status and impact of research on human pluripotent stem cells: cell lines and their use in published research.-8. Gliosarcoma stem cells: glial and mesenchymal differentiation.-9. Generation of induced pluripotent stem cells from mesenchymal stromal cells derived from human third molars (method).-10. Self-renewal and differentiation of intestinal stem cells: role of hedgehog pathway.-11. Hematopoietic stem cell repopulation after transplantation: role of vinculin.-12. Guoliang meng and derrick rancourt static and suspension culture of human embryonic stem cells.-13. Generation of marmoset induced pluripotent stem cells using six transcription factors (method).-14 Myc as a multifaceted regulator of pluripotency and reprogramming. CANCER STEM CELLS.-15. Veronica catalano, antonina benfante, giorgio stassi, and matilde todaro human thyroid cancer stem cells.-16. Tumor stem cells: cd133 gene rugulation and tumor stemness.-17. Cripto-1: a common embryonic stem cell and cancer cell marker. DISEASES.-18. Treatment of heart disease: use of transdifferentiation methodology for reprogramming adult stem cells.-19. Rat mesenchymal cell cd44 surface markers: role in cardiomyogenic differentiation.-20. Stroke therapy using menstrual blood stem-like cells: method.-21. Spontaneous cerebral stroke in rats: differentation of new neurons from neural stem cells.-22. Neurogenesis in the cerberal cortex after stroke.-23. Ex vivo expanded hematopoietic stem cells for ischemia.-24. Breast cancer risk: role of somatic breast stem cells.-25. Replacement therapy in neurodegenerative disease using induced pluripotent stem cells.-26. Treatment of graft-versous-host disease using allogeneic mesenchymal stem cells.-27. Adult neurogenesis in etiology and pathogenesis of alzheimar’s disease. TISSUE REPAIR (REGENERATION).-28. Generating human cardiac muscle cells from adipose-derived stem cells.-29. Mesenchymal stem cells and mesenchymal-derived endothelial cells: repair of bone defects.-30. Omentum in the repair of injured tissue: evidence for omental stem cells.-31. Human embryonic stem cells transplanted into mouse retina induces neural differentiation.-32. Stem cells to repair retina: from basic to applied biology.-33. Heterogeneous responses of human bone marow stromal cells (multipotent mesenchymal stromal cells) to osteogenic induction.-34. Adipose-derived stem cells and platelet-rich plasma: implications for regenerative medicine.-35. Skeletal muscle-derived stem cells: role in cellular cardiomyoplasty.-36. Cardiac regenerative medicine without stem cell transplantation.-37. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cells: therapy for acute myocarditis.-38. Patients with cancer or hematopoietic stem cell transplant: infection with 2009 h1n1 influenza. Index.